Valuation, from the filing
| Public float | $1.97B | Market value of stock held by non-affiliates, as stated on the cover page for 2025-03-28 |
|---|---|---|
| Float per share | $101.74 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / net income | 30.0× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / revenue | 1.2× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 2.0× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-03-28, not today, and each multiple below it uses the figures for the fiscal year ending 2025-09-27 — the year that filing covered.
Valuation over time
30.0× earnings today, against a median of 26.7× across 10 years on record. Above its own history.
| Float measured | Public float | Float / net income | |
|---|---|---|---|
| 2025-03-28 | $1.97B | 30.0× | |
| 2024-09-28 | $2.18B | 25.2× | |
| 2023-03-24 | $2.20B | 27.9× | |
| 2022-03-25 | $2.36B | 50.0× | |
| 2021-03-26 | $2.40B | 43.1× | |
| 2020-03-28 | $1.73B | 94.5× | |
| 2019-03-29 | $2.39B | 25.2× | |
| 2018-03-29 | $2.04B | 19.7× | |
| 2017-03-24 | $2.02B | 25.6× | |
| 2016-03-24 | $1.57B | 20.6× |
Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.
J&J SNACK FOODS CORP (JJSF) reported revenue of $1.52B and net income of $49.27M for the fiscal year ended 2026-06-27. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from J&J SNACK FOODS CORP’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2026-06-27 |
|---|---|
| Revenue | $1.52B |
| Cost of revenue | $1.05B |
| Gross profit | $476.55M |
| Operating income | $60.18M |
| Net income | $49.27M |
| Research & development | Unavailable |
| Weighted-average diluted shares | Unavailable |
| Pretax income | $61.49M |
| Income tax expense | $12.22M |
| Diluted EPS | Unavailable |
| Selling, general & administrative | $209.52M |
| General & administrative | $80.73M |
| Selling & marketing | $128.79M |
Balance
| Metric | 2026-06-27 |
|---|---|
| Cash & equivalents | $63.10M |
| Total assets | $1.36B |
| Current assets | $462.26M |
| Total liabilities | Unavailable |
| Current liabilities | $197.32M |
| Total equity incl. NCI | $892.08M |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | $171.41M |
| Accounts receivable | $210.54M |
| Goodwill | $185.07M |
| Long-term debt | $28.00M |
| Accounts payable | $97.61M |
Cash flow
| Metric | 2026-06-27 |
|---|---|
| Operating cash flow | $166.87M |
| Capital expenditures | $74.87M |
| Investing cash flow | -$73.69M |
| Financing cash flow | -$110.40M |
| Net change in cash | -$14.28M |
| Stock-based compensation | $6.42M |
| Common dividends paid | $60.94M |
| Common share repurchases | $77.73M |
| Depreciation & amortization | $75.55M |
Derived
| Metric | 2026-06-27 |
|---|---|
| Free cash flow | $92.00M |
| Gross margin | 31.3% |
| Operating margin | 3.9% |
| FCF margin | 6.0% |
| SBC / revenue | 0.4% |
| Current ratio | 2.34x |
| Revenue YoY growth | Unavailable |
| Net margin | 3.2% |
| R&D / revenue | Unavailable |
| CapEx / revenue | 4.9% |
| Long-term debt / equity | 0.03x |
| Effective tax rate | 19.9% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open JJSF in the interactive workspace to inspect any figure back to its filing.
Source filings
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.